ABA Emerging Issues in Healthcare Law Conference
BRG is home to renowned thought leaders and experts considered authorities in their fields of work. Our timely research and perspectives provide analysis and insights on the most important issues facing the industries and organizations we serve.
American Bar Association Health Law Section
Alyson Wooten discussed “Experimental Medicine: The FDA’s Role, Litigation, and Risk Management Trends” on April 28. Healthcare consumers often demand access to and coverage for experimental and investigational treatments for serious and terminal illnesses. This session covered trends in Food and Drug Administration (FDA) approval, litigation, and risk management, including the FDA approval process, experimental medicine trends during the COVID-19 pandemic, ivermectin and similar litigation, and the role of courts in setting the standard of care for providers or medical necessity standards for insurers. The session also covered risk management tips for hospital systems and other providers.
Find out more. BRG was a sponsor.
Related Professionals
Prepare for what's next.
ThinkSet magazine, a BRG publication, provides nuanced, multifaceted thinking and expert guidance that help today’s business leaders adopt a more strategic, long-term mindset to prepare for what’s next.